Significant biosimilar activities this week include:

  • 31 Jul 20, US: Vizient has advised its member health groups to utilise biosimilars to hedge against drug price inflation and the impacts of COVID-19.  Vizient predicts that drug prices in the US will increase by 3...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags